Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-426-4 | CAS number: 7128-64-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The oral LD50 was determined to be greater than 10000 mg/kg bw. Responses to the administered test substance were negligible. No deaths occurred at any dosage levels used. The LC50 by inhalation determined after an observation period of 14 days in rats of both sexes, exposed to the substance for four hours is greater than 1820 mg/m3 (highest concentration possible). No toxic symptoms were observed.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1963
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- no data on sex, limited details on animal husbandry, limited details on test compound, observation period not specified, no details on examinations
- GLP compliance:
- no
- Remarks:
- prior to GLP
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: about 120 g - Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Doses:
- 1000, 3000, 6000, 10000 mg/kg
- No. of animals per sex per dose:
- 5 animals (sex not specified)
- Control animals:
- no
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 10 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no mortality occurred
- Mortality:
- none
- Interpretation of results:
- GHS criteria not met
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 10 000 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1976
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Principles of method if other than guideline:
- Inhalation toxicity was tested according to the method of Sachsse et al. (1973): Measurement of inhalation toxicity of aerosols in small laboratory animals. In: Proceedings of the Europ. Soc. for the Study of Drug Toxicity, Vol. XV, pp. 239-251, Zurich, June 1973.
- GLP compliance:
- no
- Remarks:
- prior to GLP
- Species:
- rat
- Strain:
- other: Tif: RAIf (SPF) strain
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: in-house
- Weight at study initiation: 190 - 195 grams
- Housing: Macrolon cages, type 4 (9 animals to a cage)
- Diet: rat food - NAFAG, Gossau SG; ad libitum
- Water: ad libitum
- Acclimation period: 4 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 1
- Humidity (%): 55 +/- 5
- Photoperiod (hrs dark / hrs light): 10/14 - Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- nose/head only
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: "Grafix Exaktomat Injector"
- Method of holding animals in test chamber: PVC tubes
- System of generating particulates/aerosols: nozzle under a pressure of 2 atm at a rate of 20 L/min
- Method of particle size determination: Cascade Impactor with selectron filters
- Relative humidity: 32%
TEST ATMOSPHERE
- Brief description of analytical method used: gravimetry
- Samples taken from breathing zone: yes
VEHICLE
- Composition of vehicle: air
TEST ATMOSPHERE
- Particle size distribution:
> 7 µm: ca. 56%
3-7 µm: ca. 15%
1-3 µm: ca. 11%
< 1µm: ca. 18% - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- determined gravimetrically
- Duration of exposure:
- 4 h
- Concentrations:
- 1820 mg/m³ air (maximum achievable concentration)
- No. of animals per sex per dose:
- 9 animals
- Control animals:
- no
- Details on study design:
- The animals were submitted to a necropsy at the end of the observation period.
- Statistics:
- The average dust concentration was gravimetrically determined.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 1 820 mg/m³ air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: Average dust concentration, gravimetrically determined
- Mortality:
- No deaths observed
- Clinical signs:
- other: During the 4-hour exposure period and the subsequent 14-day observation period no toxic symptoms were observed.
- Gross pathology:
- No substance related gross organ changes were seen.
- Other findings:
- aerosol concentration: 1820 +/- 69 mg/m³
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 1 820 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute toxicity: oral route
In an acute toxicity study (similar to OECD401) the range of mortality following oral administration of the test substance was assessed. Groups of 5 rats were treated by gavage with the test article at dose levels of 1000, 3000, 6000 and 10000 mg/kg body weight. The LD50 was determined to be greater than 10000 mg/kg bw. Responses to the administered test substance were negligible. No deaths occurred at any dosage levels used.
Acute toxicity: inhalation route
Aim of the study was to provide information on health hazards likely to arise from short-term exposure by the inhalation route. The test substance was tested by the exposure of albino rats (9 animals per sex) to an aerosol generated from this product. The study is equivalent to the OECD guideline 403. A concentration of 1820 +/- 69 mg/m³ (highest achievable concentration) was tested. During the 4-hour exposure period and the subsequent 14-day observation period no toxic symptoms were observed. No substance related gross organ changes were seen. The LD50 of the test substance determined after an observation period of 14 days in rats of both sexes, exposed to the substance for four hours is therefore greater than 1820 mg/m³ air.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008 (CLP). As a result the test substance is not considered to be classified for acute oral toxicity and for acute inhalation toxicity under Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.